Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN)

Market Cap	2.70B
Revenue (ttm)	4.17B
Net Income (ttm)	441.66M
Shares Out	19.00M
EPS (ttm)	23.27
PE Ratio	6.11
Forward PE	n/a
Dividend	2.00 (1.41%)
Ex-Dividend Date	Aug 14, 2025

Volume	7,222
Average Volume	18,705
Open	146.89
Previous Close	146.69
Day's Range	141.02 - 146.97
52-Week Range	136.00 - 238.69
Beta	0.54
RSI	39.46
Earnings Date	Jan 31, 2026

About Nath Bio-Genes (India)

Nath Bio-Genes (India) Limited engages in the production, processing, and marketing of hybrid and GM seeds in India and internationally. It operates in two segments, Agricultural Activities and Trading Activities. The company offers fiber and oil seeds, including cotton and mustard; seeds for field crops, such as bajra, corn, paddy, wheat, and jowar; fruit seeds; and seeds for vegetables comprising cabbage, chilli, onion, okra, tomato, brinjal, bottle gourd, bitter gourd, sponge gourd, ridge gourd, cucumber, coriander, sweet pepper, green peas,...

• Industry: Agricultural Inputs
• Sector: Materials
• Founded: 1979
• Employees: 451
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: NATHBIOGEN

Financial Performance

In 2024, Nath Bio-Genes (India)'s revenue was 3.65 billion, an increase of 9.70% compared to the previous year's 3.33 billion. Earnings were 386.00 million, a decrease of -2.57%.